Key result
Leadless and modular pacemakers reduce chronic complications, reinterventions, and infections versus transvenous systems.
Why the study?
Leadless pacing technology has evolved rapidly, but a comprehensive summary of its development, clinical applications, and future modular concepts is needed.
This review highlights how modular leadless pacing systems eliminate lead- and pocket-related complications while allowing staged, patient-tailored upgrades from single-chamber pacing to dual-chamber, defibrillator-integrated, and resynchronization therapy.
Answers are grounded in this paper and cite their sources.
May guide selective adoption to minimize infections; leaves open the need for RCTs confirming modular upgrade durability.
Leadless pacemakers have reshaped the approach to cardiac pacing by eliminating transvenous leads and subcutaneous pockets. Since the introduction of the first leadless pacemakers, leadless pacing has advanced from single-chamber ventricular systems to atrioventricular synchronous pacing, standalone atrial pacing, and fully leadless dual-chamber platforms, enabling patient-tailored pacing therapy. The modular leadless pacing concept allows a standalone leadless pacing device to be implanted initially, with additional leadless devices added sequentially as pacing requirements evolve, minimizing unnecessary hardware while preserving the option for future pacing upgrades. This modular approach has expanded to include integration with subcutaneous implantable cardioverter-defibrillators and leadless cardiac resynchronization therapy, moving towards a fully leadless cardiac rhythm management ecosystem. This review summarizes the evolution of leadless pacing, compares currently available devices and their clinical applications, explains leadless pacemaker implantation and end-of-life management, and explores the modular leadless pacing concept as the foundation for future fully leadless cardiac rhythm management.
No takes yet. Share an insight, caveat, or question.
Al-Mir et al. (2026) conducted a review in Cardiac arrhythmias and conduction disorders requiring permanent cardiac pacing. Leadless and modular cardiac pacing systems (e.g., Micra, Aveir, EMPOWER LP, WiSE-CRT) vs. Conventional transvenous pacemakers (TV-PM) was evaluated. Leadless and modular cardiac pacing systems reduce chronic complications, device reinterventions, and infections compared with transvenous pacemakers while enabling tailored pacing upgrades.
Synapse has enriched 10 related papers. Consider them for comparative context: